Drugs & Devices
Lilly’s Zepbound Shows Promising Results in Sleep Apnea Clinical Trials
Zepbound (tirzepatide), originally for weight management, shows potential as a treatment for sleep apnea by reducing symptoms and aiding significant weight loss.